CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction
Authors:
- Joyce BischoffJBJoyce Bischoff
- Guillem CasanovasGCGuillem Casanovas
- Jill Wylie-SearsJWJill Wylie-Sears
- Dae-Hee KimDKDae-Hee Kim
- Jonathan BeaudoinJBJonathan Beaudoin
- 11 November 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 119 (11) , 1215-1225
Abstract
Rationale: : Ischemic mitral regurgitation, a complication after myocardial infarction (MI), induces adaptive mitral valve (MV) responses that may be initially beneficial but eventually lead to leaflet fibrosis and MV dysfunction. We sought to examine the MV endothelial response and its potential contribution to ischemic mitral regurgitation. Objective: : Endothelial, interstitial, and hematopoietic cells in MVs from post-MI sheep were quantified. MV endothelial CD45, found post MI, was analyzed in vitro. Methods and Results: : Ovine MVs, harvested 6 months after inferior MI, showed CD45, a protein tyrosine phosphatase, colocalized with von Willebrand factor, an endothelial marker. Flow cytometry of MV cells revealed significant increases in CD45 + endothelial cells (VE-cadherin + /CD45 + /α-smooth muscle actin [SMA] + and VE-cadherin + /CD45 + /αSMA− cells) and possible fibrocytes (VE-cadherin − /CD45 + /αSMA + ) in inferior MI compared with sham-operated and normal sheep. CD45 + cells correlated with MV fibrosis and mitral regurgitation severity. VE-cadherin + /CD45 + /αSMA + cells suggested that CD45 may be linked to endothelial-to-mesenchymal transition (EndMT). MV endothelial cells treated with transforming growth factor-β1 to induce EndMT expressed CD45 and fibrosis markers collagen 1 and 3 and transforming growth factor-β1 to 3, not observed in transforming growth factor-β1–treated arterial endothelial cells. A CD45 protein tyrosine phosphatase inhibitor blocked induction of EndMT and fibrosis markers and inhibited EndMT-associated migration of MV endothelial cells. Conclusions: : MV endothelial cells express CD45, both in vivo post MI and in vitro in response to transforming growth factor-β1. A CD45 phosphatase inhibitor blocked hallmarks of EndMT in MV endothelial cells. These results point to a novel, functional requirement for CD45 phosphatase activity in EndMT. The contribution of CD45 + endothelial cells to MV adaptation and fibrosis post MI warrants investigation.Keywords
This publication has 50 references indexed in Scilit:
- Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic processJournal of Molecular and Cellular Cardiology, 2011
- Mitral Valve Endothelial Cells With Osteogenic Differentiation PotentialArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Fibrocytes in health and diseaseExperimental Hematology, 2010
- Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosisThe International Journal of Biochemistry & Cell Biology, 2010
- Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax PathogenesisJournal of Biological Chemistry, 2009
- CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabeculesJournal of Experimental Medicine, 2008
- Standardization of real-time PCR gene expression data from independent biological replicatesAnalytical Biochemistry, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- The role of TGF-β signaling in myocardial infarction and cardiac remodelingCardiovascular Research, 2007
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001